The prevalence of diabetes has alarmingly increased in both developed and developing countries in recent years. The prevalence of different complications and comorbid conditions associated with diabetes has also rampantly increased, thereby endangering the lives of patients with diabetes. In fact, obesity, which is associated with diabetes, is currently a major global public health concern. Nevertheless, it can be argued that little progress has been made in the field of the management of diabetes during the past decades, and many believe that the discovery of insulin was not followed by further significant advancements in the management of diabetes.
Diagnostic and screening approaches to diabetes have considerably evolved in recent decades. Saccharometers are replaced by glucometers and elaborated laboratory techniques. However, there are still limitations to such technologies, and they cannot be used on large scales, and, in pediatric endocrinology, they are not well complied with. In fact, it may be argued that the progress we have made in the management of diabetes has mainly focused on the invention of more efficient insulin preparations and improved techniques for its delivery.
Notwithstanding the shortcomings, there have been positive signs of progress in terms of curative approaches to diabetes. Although initially considered unsuccessful, Pancreas transplantation is expected to be applied on a large scale in the future as immunosuppressive strategies develop further. Pancreatic islet-cell transplantation is yet another potentially curative option for diabetes. However, the shortage of donors poses great limitations to this procedure. Fortunately, stem cells are suitable alternatives for pancreatic cells, even though many technical and ethical concerns hinder stem-cell research in many countries.
The scarcity of the literature in the mentioned fields, however, can be considered a hindrance to the further advancement of the science of diabetology. It can be argued that the key to the future development of science is interdisciplinary research. Therefore, we invite authors to submit original research and review papers investigating the new horizons in the screening, diagnosis, and treatment of diabetes.
Potential topics include, but are not limited to:
• Novel approaches to screening and diagnosis of diabetes
• Machine learning and data mining methods in diabetes research
• Personalized medicine in the diagnosis and management of diabetes
• Whole pancreas transplantation
• Pancreatic islet-cell transplantation
• The application of stem-cell technology in the treatment of diabetes
• Artificial pancreas
• Interdisciplinary advancements in the management of obesity
• New medications for the management of diabetes
• The role of traditional medicine in the diabetes management
The prevalence of diabetes has alarmingly increased in both developed and developing countries in recent years. The prevalence of different complications and comorbid conditions associated with diabetes has also rampantly increased, thereby endangering the lives of patients with diabetes. In fact, obesity, which is associated with diabetes, is currently a major global public health concern. Nevertheless, it can be argued that little progress has been made in the field of the management of diabetes during the past decades, and many believe that the discovery of insulin was not followed by further significant advancements in the management of diabetes.
Diagnostic and screening approaches to diabetes have considerably evolved in recent decades. Saccharometers are replaced by glucometers and elaborated laboratory techniques. However, there are still limitations to such technologies, and they cannot be used on large scales, and, in pediatric endocrinology, they are not well complied with. In fact, it may be argued that the progress we have made in the management of diabetes has mainly focused on the invention of more efficient insulin preparations and improved techniques for its delivery.
Notwithstanding the shortcomings, there have been positive signs of progress in terms of curative approaches to diabetes. Although initially considered unsuccessful, Pancreas transplantation is expected to be applied on a large scale in the future as immunosuppressive strategies develop further. Pancreatic islet-cell transplantation is yet another potentially curative option for diabetes. However, the shortage of donors poses great limitations to this procedure. Fortunately, stem cells are suitable alternatives for pancreatic cells, even though many technical and ethical concerns hinder stem-cell research in many countries.
The scarcity of the literature in the mentioned fields, however, can be considered a hindrance to the further advancement of the science of diabetology. It can be argued that the key to the future development of science is interdisciplinary research. Therefore, we invite authors to submit original research and review papers investigating the new horizons in the screening, diagnosis, and treatment of diabetes.
Potential topics include, but are not limited to:
• Novel approaches to screening and diagnosis of diabetes
• Machine learning and data mining methods in diabetes research
• Personalized medicine in the diagnosis and management of diabetes
• Whole pancreas transplantation
• Pancreatic islet-cell transplantation
• The application of stem-cell technology in the treatment of diabetes
• Artificial pancreas
• Interdisciplinary advancements in the management of obesity
• New medications for the management of diabetes
• The role of traditional medicine in the diabetes management
